Metacare메타케어
118000 · KOSPI · ₩118000 · 메타케어
₩997▼ ₩301 (23.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩33B | ₩20B | ₩56B | ₩19B | ₩19B |
| Cost of sales | ₩23B | ₩13B | ₩49B | ₩13B | ₩14B |
| Gross profit | ₩10B | ₩7.7B | ₩7.1B | ₩6.5B | ₩5.1B |
| Operating income | ₩1.3B | ₩1.5B | −₩8.9B | −₩300M | −₩1.8B |
| Net income | −₩212M | ₩8.4B | −₩26B | −₩50B | ₩7.8B |
| Net income to shareholders | ₩498M | ₩9.3B | −₩15B | −₩50B | ₩7.7B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩198B | ₩157B | ₩155B | ₩190B | ₩176B |
| Current assets | ₩29B | ₩43B | ₩53B | ₩73B | ₩82B |
| Cash and equivalents | ₩1.6B | ₩30B | ₩20B | ₩28B | ₩59B |
| Total liabilities | ₩77B | ₩41B | ₩18B | ₩60B | ₩57B |
| Current liabilities | ₩52B | ₩12B | ₩16B | ₩48B | ₩53B |
| Borrowings | ₩59B | ₩35B | ₩2.5B | ₩34B | ₩30B |
| Total equity | ₩121B | ₩116B | ₩138B | ₩130B | ₩119B |
| Shareholders' equity | ₩119B | ₩116B | ₩106B | ₩99B | ₩119B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩2.4B | ₩4.5B | −₩13B | −₩2.5B | −₩1.5B |
| Capital spending | ₩2.7B | ₩693M | ₩535M | ₩109M | ₩26M |
| Free cash flow | −₩245M | ₩3.8B | −₩13B | −₩2.6B | −₩1.5B |
Consolidated where available. Amounts in won.
Also known as: Metacare / 메타케어 / 118000 / KRX:118000
Source: KRX statistical information